Author: Justin Mckibben
Earlier this week we talked about a story that shook things up in politics as a former DEA agent threw some serious accusations at the Big Pharma industry, Congress and a number of key officials for their involvement in policies some believe helped create the enduring opioid crisis in America. Among those accused of tipping the scales in favor of Big Pharma and stripping power away from those charged with regulating the industry was Republican Representative Tom Marino.
Of course, we know that Tom Marino was President Donald Trump’s top nominee to be the nation’s drug czar.
Now, after withdrawing from the nomination to head the White House Office of National Drug Control Policy, Tom Marino says he is proud of his role in writing a 2016 law that many critics say paved the way for the current epidemic.
The Tom Marino Factor
What kind of role did Tom Marino have in the creation of the Ensuring Patient Access and Effective Drug Enforcement Act? Why is it that so many are up in arms about the bill in the first place?
To recap- Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee introduced a bill to the House. It was advertised to officials as a way to ensure that patients had access to the pain medication they needed. In a statement released by Marino’s office, he claims the law would help “facilitate a balanced solution” by ensuring access to certain medications while allowing the Drug Enforcement Administration to prevent the sale and abuse of prescription drugs.
In essence, Tom Marino was supposedly pushing for a way to let pain management patients still get the useful medications they needed, without impeding on the process of curbing abuse.
But that isn’t how everyone sees it, especially after the 60 Minutes story.
Why it Matters
According to the opposition, the bill ultimately did little else besides weaken the DEA and the government’s authority to stop companies from distributing opioids in suspicious shipments.
For years prior to the passage of the “Marino Bill” some big-time drug distributors were getting fined thousands of dollars for repeatedly ignoring DEA warnings to shut down suspicious sales of hundreds of millions of pills. These companies were racking up billions of dollars in sales while turning a blind eye to obnoxious overprescribing of dangerous drugs.
Back then the DEA was able to immediately prevent drugs from reaching the street by freezing suspicious shipments. If the DEA judged that the drugs posed an “imminent danger” to a community, they could take action to prevent the flood of powerful narcotic medications from overwhelming the area.
However, the Tom Marino bill is argued to make it virtually impossible for the DEA to freeze suspicious narcotic shipments from the companies. Now, the agency is required to demonstrate that a drug distributor’s actions represent “a substantial likelihood of an immediate threat,” which officials say is far more difficult criteria to meet. The report against the Tom Marino bill even cited internal DEA and Justice Department documents and an independent assessment by the DEA’s chief administrative law judge.
The DEA even fought the bill, according to people within the agency, but in 2015 the law gained momentum again when the Justice Department named a new chief of the DEA- Chuck Rosenberg. After some reluctance, the report on 60 Minutes that included exclusive insight from Joseph T. Rannazzisi states the DEA ultimately took a deal they did not want.
Champion for Big Pharma
Marino disputed that, calling the reports “false accusations and unfair reporting.”
Tom Marino spent years pushing versions of this bill through Congress. He argued that it was to put an overly-aggressive DEA in check and protect drug companies from what he believed was unfair or misguided federal interference. In other words, he spent a lot of time fighting for Big Pharma’s ability to send millions of pills to communities that didn’t have half the population to justify them. All because the DEA was being aggressive?
The irony here is that the same people who pushed so hard for drug distributors ability to traffic obscene among of pills without the pesky DEA would probably be the same people demanding mandatory minimums for low-level drug offenders on the streets.
And again, many are still suspicious of those involved in pushing for this kind of legislation because of their connections to Big Pharma industry. The Post reports that the drug industry worked behind the scenes with lobbyists and key members of Congress, including Tom Marino.
Some reports indicate the Big Pharma industry poured more than a million dollars into election campaigns, including Marino’s, who received nearly $100,000 in campaign contributions from political action committees supporting the drug industry.
Utah Republican Senator Orrin Hatch calls the report “complete baloney” after it gained serious momentum earlier in the week.
Why are we not surprised? Because Hatch himself has received hundreds of thousands in donations from Big Pharma companies and health contributors over the years.
Holding Big Pharma accountable for their contribution to the opioid epidemic has become an increasingly popular cause. Lawyers and politicians at all levels have been pushing to put a spotlight on the shady side of the pharmaceutical industry. Now it seems that spotlight may extend more and more to exposing the politics that allow these issues to spread.
Another crucial element to putting an end to the opioid epidemic is providing safe and effective treatment for those who need help the most. A lot of people are still out there suffering because of prescription drug abuse or other dangerous substances. But we want to help. If you or someone you love is struggling, please call toll-free now.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Ever since the true nature of the opioid epidemic in America began to come to light, and people started to see the gravity of its impact in communities across the country, there have been plenty of efforts to find out how we ever got this far. We continue to ask who should be held accountable. Was it the black market drug trade? Was it the synthetic opioids coming from overseas? How did it get this bad?
Just this past week 60 Minutes and The Washington Post joined forces to interview Joe Rannazzisi, who is said to be the most important whistleblower ever on 60 Minutes.
Joe Rannazzisi is a former agent of the Drug Enforcement Administration (DEA) who ran the Office of Diversion Control; the department in charge of regulating and investigating the pharmaceutical industry. He is a former DEA deputy assistant administrator with a law degree, and a pharmacy degree, who believes the great injustice done to the American people cannot go overlooked.
Bad Business with Big Pharma
Through this inside look with Rannazzisi, he implicates Big Pharma drug makers in willingly distributed hundreds of millions of drugs to rogue pharmacies and pain-clinics-turned-pill-mills for over two decades.
Rannazzisi believes that the Big Pharma companies, some even multi-billion, Fortune 500 companies, have contributed to the problem by ignoring the truth; that powerful prescription pain medications were being diverted from doctors, clinics and pharmacies for illicit use. In the interview, Rannazzisi calls out a number of key drug makers, including:
He also calls out the three largest drug distributors:
- Cardinal Health
Saying they control probably 85%- 90% of drugs “going downstream.”
In fact, Rannazzisi said the way pain clinics seemed to pop up overnight all over the country made the whole crack-cocaine epidemic look like nothing, saying he had never seen anything like it, adding:
“These weren’t kids slinging crack on the corner. These were professionals who were doing it. They were just drug dealers in lab coats.”
Rannazzisi says after prosecuting pain doctors and pharmacists didn’t seem to put a real dent in the problem, he knew he had to work his way up; they went after distributors.
While drug distributors tried to defend themselves saying it was all on the doctors for over-prescribing medications, Rannazzisi says they know exactly how many pills are being sent out. Under the Controlled Substances Act, these distributors are required by law to report and stop what the DEA refers to as “suspicious orders”.
So what might “suspicious orders” look like? Probably something lie unusually large and/or frequent shipments of opioids being made to a location. Kind of like what was happening all over the nation for years and years.
For example, just one pharmacy in Kermit, West Virginia ordered 9 million hydrocodone pills in just over 2 years. That’s for a town of only 392 people. That’s over 11,479 pills a person each year! Almost 1,000 pills a month! From only one of the town’s pharmacies.
DEA investigators say many drug distributors ignored the DEA requirements and shipped anyway.
DEA Fighting Back
Rannazzisi wasn’t the only DEA agent to speak up about Big Pharma’s bad business. Several other DEA veterans say they saw thousands of suspicious orders and tried to fight the growing problem. Others said they tried on multiple occasions to get these companies to fix the issue, but they did nothing.
Eventually, in 2008 the DEA was able to hit some distributors with hefty fines for filing hundreds of suspicious orders, including:
- $13.2 million fine against the country’s largest drug distributor, McKesson
- $34 million fine against second-largest distributor, Cardinal Health
The fines for drug distributors over the last 7 years add up to around $341 million.
The High Rollers
In 2011, Cardinal Health attorneys called Rannazzisi’s boss at the Justice Department, who called Rannazzisi and pressed for an explanation for his policies. Rannazzisi believes that even after they had gone after small companies hundreds of times before, as soon as they went after the Fortune 500 drug makers, their power and influence started getting in his way.
Rannazzisi says that with these massive Big Pharma empires there was now money and influence being used to pressure top lawyers at the DEA to pursue a softer approach on penalizing drug distributors who broke the rules.
Former DEA attorney Jonathan Novak noticed that shocking shift in the way these kinds of cases were handled. Stating:
“These were not cases where it was black — where it was grey… These were cases where the evidence was crystal clear that there was wrongdoing going on.”
But suddenly the higher ups started to demand more and more evidence to stall the system. Fewer cases against Big Pharma companies were being approved, and road-blocks from Novak’s bosses seemed to pop up everywhere.
Novak also said he saw a huge migration of DEA lawyers switching sides to defend the drug industry in higher paying positions.
Taking it to Congress
While drug distributors started successfully stalling the progress of cases against them from the DEA, they also began to lobby Congress to get legislation that would destroy the DEA’s power over them.
Then one day Pennsylvania Congressman Tom Marino and Congresswoman Marsha Blackburn of Tennessee introduced a bill to the House that was promoted as a way to ensure that patients had access to the pain medication they needed. However, Jonathan Novak, who worked in the DEA’s legal office, claims that what the bill really did was strip the agency of its ability to immediately freeze suspicious shipments of prescription narcotics to keep drugs off U.S. streets.
The bill’s author… Linden Barber, a former employee of the DEA.
Congressman Tom Marino, along with Congresswoman Blackburn, later wrote the inspector general for the Justice Department, demanding that Rannazzisi be investigated for trying to quote “intimidate the United States Congress.” Even though this went nowhere, Rannazzisi was stripped of his responsibilities soon after.
Some former DEA agents believe that the Big Pharma industry not only used lobbying groups to donate money to politicians to get laws passed in their favor, but also to try and push Joe Rannazzisi out of his office.
In the end, the DEA signed off on the final version of the “Marino bill.” A senior DEA representative claiming that even though they fought to stop it, growing pressure from Congress and industry lobbyists forced them into a deal it did not want.
The bill was presented to the Senate in March of 2016.
Majority Leader Mitch McConnell introduced the legislation in the Senate.
It passed by unanimous consent with no objections and no recorded votes.
It passed the House the same way, and President Obama signed it into law.
Where Are We Now?
This whole thing reminds you of the saying- if you can’t beat em, join em.
It would seem that’s exactly what a lot of DEA agents did after fighting a losing battle against powerful Big Pharma companies.
Since it all began, the pharmaceutical industry and law firms that represent them have hired at least 46 investigators, attorneys, and supervisors from the DEA, including 32 directly from the division that regulates the drug industry.
Remember that guy Linden Barber, who authored the bill that many say stripped the DEA of the power to go after Big Pharma companies? Well 3 months ago Cardinal Health, that second-largest drug distributor we were talking about that went after Rannazzisi through his boss, hired Linden Barber as the senior vice president!
Other former DEA agents and lawyers have gone on to take up so pretty prestigious positions working for drug companies, or law firms and other organizations working in the pharmaceutical industries best interest.
Joe Rannazzisi now consults with state attorneys general who have filed suit against distributors for their role in the opioid crisis.
Oh… and let us not forget Congressman Marino, who was just nominated to become President Trump’s new drug czar.
Remarkably, there are a lot of instances of people in the DEA being influenced by pharmaceutical companies and lobbyists to stand up for drug companies instead of the tens-of-thousands of Americans dying from opioids each year. In many of these instances, the individual’s go on to get high-earning jobs defending the interests of the Big Pharma industry.
So is it a made-up conspiracy? Or are pharmaceutical companies buying their way out of trouble at every turn and pushing out people like Rannazzisi who stand up to them? Is it really that hard to believe when you connect the dots?
With an ongoing opioid epidemic doing major damage to the country, we have to acknowledge everything that has contributed to this issue. Even if we set aside the idea of placing blame, we cannot prevent it from getting worse or happening again if we don’t acknowledge what helped cause it. Every drug company, policy maker, pharmacy, crooked doctor and individual should be accountable to taking action to make things better. It starts with accepting the issue and building a foundation to recover. If you or someone you love is struggling, please call toll-free now. We want to help.
CALL NOW 1-800-951-6135
Author: Shernide Delva
The Drug Enforcement Administration is hosting another National Prescription Drug Take-Back Day on October 22, 2016. Hosted nationwide, the DEA will use the day to provide a responsible means of disposing of prescription drugs. Another focus will be educating the public about the potential for misuse and abuse of these medications.
“Eighty percent of new heroin users started by using opioid prescription drugs,” explains DEA Special Agent in Charge James Hunt. “DEA’s National Prescription Pill Take-Back Initiative is a way for families to prevent drug use, abuse, and overdoses by ridding their medicine cabinets of unused, unwanted and expired medication.”
Released last month, the 2015 National Survey on Drug Use and Health estimates that approximately 6.4 million Americans age 12 and over abuse prescription drugs. The same survey showed that each and every day, 2,500 teens take a prescription drug to get high for the first time.
Reason for Take-Back Day
Prescription drug abuse exceeds the total drug abuse of cocaine, heroin, magic mushrooms, LSD, mescaline, and methamphetamine combined. Since drug overdoses are now the leading cause of injury-related death in the United States, it is more crucial than ever to have a drug-take-back day in this country. Drug overdoses kill more people than car accidents.
Furthermore, at the last semi-annual event in April, more than 893,498 pounds of unwanted medicines were collected at 5,400 sites spread across 50 states. Together, this totals an incredible 447 tons of medications, exceeding the previous record of 390 tons back in spring 2014.
According to the DEA press release, the top five states with the largest collections were:
- Texas (almost 40 tons)
- California (32 tons)
- Wisconsin (31 tons)
- Illinois (24 tons)
- Massachusetts (24 tons)
Over the past six years, the DEA has collected and destroyed about 6.4 million pounds of unused prescription drugs in total. More than 3,800 members of local law enforcement agencies and community partners participate in the program. National Drug Take-Back Day is not going anywhere and will continue to be an unqualified success. It clearly is needed more than ever before.
DEA Special Agent in Charge, Stephen G. Azzam, points out,
“Prescription drug abuse has become the nation’s fastest-growing drug problem, destroying countless lives. The DEA’s Take-Back initiative provides another way to address this epidemic and a safe way for our citizens to dispose of their unwanted prescription drugs and reduce the threat they pose to public health and safety.”
If you would like to locate a National Prescription Drug Take-Back collection site near you, please check out this helpful link.
Drug addiction is an epidemic spreading worldwide. Drug overdoses are taking away lives at tragic numbers. Prevent the drugs in your home from abuse by disposing of them correctly. Participate in National Prescription Drug Take Back day. If you or someone you love is struggling with substance abuse or addiction, please call toll-free today.
CALL NOW 1-800-951-6135
Author: Shernide Delva
Recently, we wrote about how the Drug Enforcement Administration (DEA) made the controversial decision to ban kratom by making it a Schedule I drug. While the ban is set to go into effect by the end of this week, advocates of the herbal supplement refuse to go down without a fight. A bipartisan group of 51 House lawmakers recently joined the chorus of opposition to the DEA’s upcoming ban.
To give a quick overview: Back in late August, the DEA announced it would prohibit kratom due to various reports of health implications associated with the use of the drug. The ban would temporarily add Kratom to the schedule 1 category of narcotics along with substances like Marijuana, heroin, and LSD.
The DEA made it clear the decision was due to kratom’s high potential for abuse and the lack of medical benefit of the drug. However, advocates passionately argue that kratom is useful for drug withdrawal and mental health issues like anxiety and depression.
Therefore, placing kratom in the schedule 1 category would effectively ban it from those who regularly use the drug. Many users find the drug useful in treating, pain, depression, high blood pressure among other ailments.
The ban sparked a broad range of controversy. Now, members of Congress have joined the chorus of opposition. A bipartisan group of 51 House Representatives just signed a letter urging DEA Administrator Chuck Rosenberg to delay the ban.
“As our nation continues to combat the public health crisis of opioid abuse, the federal government has invested significant resources to develop alternative pain management strategies,” reads the letter.
The letter urged the delay to continue the federally funded study of kratom as a possible treatment option for opioid withdrawal. By placing kratom on the Schedule I category, the letter states it will “put a halt on federally funded research and innovation surrounding the treatment of individuals suffering from opioid and other addictions.”
While kratom is not for everyone, many find it a compelling alternative to prescription drugs. Earlier this month, Susan Ash, founder of the American Kratom Association, revealed that her organization has been receiving thousands of calls from people across the United States concerned about losing kratom and resorting to prescription drugs instead.
“I am completely swamped,” Ash told The Fix. “I have thousands of people afraid of relapse. People are explicitly telling us they are terrified of losing their quality of life or even their lives.”
51 House Representatives Urges Delay On Ban
The House representatives’ letter to the DEA urges them to delay the ban and allow more time to consult with “consumers, researcher, and other stakeholders.” When the ban was initially passed, the DEA did not allow any opposition in regards to their decision to ban kratom.
Instead, the DEA argued their decision was valid by citing a report by the Centers for Disease Control and Prevention which stated that kratom poisoning was the cause for 660 calls to poison centers across the country between 2010 and 2015. The DEA argued that these numbers clearly indicated the need for the ban. They also pointed to 16 reported kratom-related deaths between 2014 and 2016 to further justify their decision.
Still, these numbers are far overshadowed by other drugs, both legal and illegal. Those in opposition point to the numbers of calls the poison control center receives over laundry pod poisonings. These calls far surpass the number of calls they receive in regards to kratom. Both the House lawmakers and kratom advocates think it is not a good idea to restrict access to Kratom when so many people are searching for safer pain relief alternatives rather than prescription pills.
“This hasty decision could have serious effects on consumer access and choice of an internationally recognized herbal supplement,” the lawmakers wrote in their letter.
Kratom does have the potential for abuse. However, it does have potential medical benefits. While the use of any drug is not ideal, the reality is harm reduction remains a crucial topic of discussion. Further research is needed before a ban on kratom is made. Do you agree with the ban?
Overall, if you are struggling with any substance abuse, legal or illegal, you need to research out for treatment. We have the tools to help in your recovery. Do not wait. Call today.
CALL NOW 1-800-951-6135
Author: Justin Mckibben
Ever since August 28, 2015 anyone and everyone seems to have something to say about Narcos, the new hit series that debuted on Netflix and has a monumental momentum that has not stopped since. The show has been talked about on practically every channel, has flooded all Facebook (not to mention other social media) news feeds, and has become a centerpiece of conversation in every medium.
Even the people who have never seen a single episode have chattered about how the plot must be well worth the hype, and everyone else eagerly awaits a second gripping and climactic season.
So why has Narcos taken over, and what hidden truths of the drug trade can we learn from it?
Narcos is an American drug trafficking crime drama television series that was created by various talented writers and producers, including:
- Chris Brancato
- Carlo Bernard
- Doug Miro
Narcos has Brazilian filmmaker José Padilha in the captains seat, and thus far he appears to have done a great deal of justice to the material.
This uniquely epic is so far a 10 installment long episodic portrayal of drug kingpin Pablo Escobar and the Medellín Cartel has a thrilling way of packing a serious punch, while also entangling the tales of United States Drug Enforcement Administration (DEA) agents.
Narcos unravels a dramatic reenactment of the real life events surrounding of the progression and expansion of cocaine drug cartels across the globe, while highlighting law enforcement efforts to bring it all crashing down. Wagner Moura stars as notorious Colombian cocaine kingpin Pablo Escobar, with plenty of blood and brutality to go around.
True Narco Cinema
The series is set during the 1980s Colombian drug war, but it’s more generally about the myths that drug lords, politicians, and cops tell the communities they serve, which has historically been a way they preserve their power; feeding into the fear and mythology that surround them.
Narcos producers call this “magical realism,” but it is actually an old Latin American genre of a storytelling tradition called “narco cinema,” comprised entirely of B-movies about the drug trade. Narco cinema works its own magic through a deeply romanticizing the power and violence of drug lords; turning cops into villains, drug kingpins into underdogs turned heroes, and beauty queens into narcos.
Underneath all this, Narco cinema skillfully exposes the weaknesses and corruption of government systems that have allowed the cartels to infect them and take advantage of the people, which is a clever way to show the truth of how cocaine and cocaine traffickers like those on Narcos have devastated the lives of those around them.
Many people who have made a habit and even a living of dissecting and evaluating films and media have praised the series, and one thing many have pointed out is even though the show has bent the truth a bit to make for more entertaining television, it may more accurately portray the uglier, more sinister side to the reality of drug cartels.
Narcos has been valued by many as the first American production in the true narco-cinematic legacy. Unlike most American depictions of the drug trade, Narcos manages to glamorize its protagonists while still revealing the disturbing structural problems they are working within, exposing the world to the key dynamics in the real life drug wars; specifically the way drug lords and corrupt cops and DEA agents mold their own myths and do everything in their power to instill those terrifying yet empowering legends about them in order to preserve their power over the people.
Drug lords oppress the people, they terrorize communities and they destroy lives across the board. Yet because they are made into these grandiose legends of rags to riches through overcoming injustice, they are idolized. What Narcos has done in the eyes of many is it has continued to stroke the ego of the drug lord just enough, while trying to show the viewer just how disturbing and tragically wicked the world of the drug dealer can be. It is not all fun and games, not all a hero’s journey. It is a twisted and ugly world, and the hidden truth they try to display is that the legend is more important to the drug lord than the truth, because the truth is a lot uglier and a lot less heroic than the stories they tell about themselves.
Along with dramatic series about drug abuse and drug trafficking, Netflix also features some excellent drug documentaries that may also give you insight into how substance abuse and addiction destroys lives. If you or someone you love is struggling with substance abuse or addiction, please call toll-free 1-800-951-6135